Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany
Abstract Background Overuse of short-acting beta-2 agonists (SABA), which do not treat the underlying inflammation of asthma, is linked to poor clinical outcomes such as increased exacerbation risk. This study, as part of the SABINA program, estimated the prevalence of SABA overuse and associated va...
Main Authors: | Heinrich Worth, Carl-Peter Criée, Claus F. Vogelmeier, Peter Kardos, Eva-Maria Becker, Karel Kostev, Ingo Mokros, Andrea Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-021-01701-3 |
Similar Items
-
It is time to change the way we manage mild asthma: an update in GINA 2019
by: Jaya Muneswarao, et al.
Published: (2019-08-01) -
Perception of asthma control among asthmatics seen inChest Clinic at Tertiary Hospital, Addis Ababa, Ethiopia
by: Tewodros H. Gebremariam, et al.
Published: (2019-10-01) -
Effective Asthma Management: Is It Time to Let the AIR out of SABA?
by: Alan Kaplan, et al.
Published: (2020-03-01) -
Overuse Knee Injuries in Athletes
by: Miroslav Kezunović
Published: (2013-03-01) -
Risk factors for uncontrolled asthma in adults
by: Juan Carlos Fernández de Córdova-Aguirre, et al.
Published: (2019-04-01)